Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BioElectronics receives product approvals

This article was originally published in The Tan Sheet

Executive Summary

Health Canada approves BioElectronics Corp.'s Allay Menstrual Pain Therapy product for OTC sale to treat menstrual pain symptoms. The Frederick, Md.-based company also announces June 29 that South Korea's regulators approved its ActiPatch for reducing muscle pain. "With its proven technology and established clinical platform, Allay and ActiPatch are very unique brands in both Canada and Korea," the company said. BioElectronics noted the approvals open doors into new markets. The firm's pain relief products already are available in 44 countries worldwide
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS104260

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel